Objective: The aim of this study was to determine various types of contraindicated medications that are administered to patients with renal insufficiency by physicians who override alerts provided by the Computerized Decision Support Systems (CDSS).
 ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻠ‬  ‫ﺨ‬  ‫ﺺ‬   ‫ﻫ‬  ‫ﺪ‬  ‫ﻑ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺒ‬  ‫ﺤ‬  ‫ﺚ‬  :  ‫ﺗ‬  ‫ﻬ‬  ‫ﺪ‬  ‫ﻑ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﺓ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺔ‬  ‫ﺇ‬  ‫ﻟ‬  ‫ﻰ‬  ‫ﺗ‬  ‫ﺤ‬  ‫ﺪ‬  ‫ﻳ‬  ‫ﺪ‬  ‫ﺃ‬  ‫ﻧ‬  ‫ﻮ‬  ‫ﺍ‬  ‫ﻉ‬  ‫ﻣ‬  ‫ﺨ‬  ‫ﺘ‬  ‫ﻠ‬  ‫ﻔ‬  ‫ﺔ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺤ‬  ‫ﻈ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺘ‬  ‫ﺨ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﻣ‬  ‫ﻬ‬  ‫ﺎ‬  ‫ﻭ‬  ‫ﺃ‬  ‫ﻋ‬  ‫ﻄ‬  ‫ﻴ‬  ‫ﺖ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﻳ‬  ‫ﻌ‬  ‫ﺎ‬  ‫ﻧ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻘ‬  ‫ﺼ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻮ‬  ‫ﻱ‬  ،  ‫ﻣ‬  ‫ﻦ‬  ‫ﻗ‬  ‫ﺒ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﻃ‬  ‫ﺒ‬  ‫ﺎ‬  ‫ﺀ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﺗ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﻭ‬  ‫ﺯ‬  ‫ﻭ‬  ‫ﺍ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﺤ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﻲ‬  ‫ﺗ‬  ‫ﻘ‬  ‫ﺪ‬  ‫ﻣ‬  ‫ﻬ‬  ‫ﺎ‬  ‫ﺃ‬  ‫ﻧ‬  ‫ﻈ‬  ‫ﻤ‬  ‫ﺔ‬  ‫ﺩ‬  ‫ﻋ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻘ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺤ‬  ‫ﺎ‬  ‫ﺳ‬  ‫ﻮ‬  ‫ﺑ‬  ‫ﻴ‬  ‫ﺔ‬  .   ‫ﻃ‬  ‫ﺮ‬  ‫ﻕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺒ‬  ‫ﺤ‬  ‫ﺚ‬  :  ‫ﺗ‬  ‫ﻤ‬  ‫ﺖ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﻩ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺔ‬  ‫ﺑ‬  ‫ﺄ‬  ‫ﺛ‬  ‫ﺮ‬  ‫ﺭ‬  ‫ﺟ‬  ‫ﻌ‬  ‫ﻲ‬  ‫ﻋ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺟ‬  ‫ﻤ‬  ‫ﻴ‬  ‫ﻊ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻨ‬  ‫ﻮ‬  ‫ﻣ‬  ‫ﻴ‬  ‫ﻦ‬  ٬  ‫ﺧ‬  ‫ﻼ‬  ‫ﻝ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻔ‬  ‫ﺘ‬  ‫ﺮ‬  ‫ﺓ‬  ‫ﻣ‬  ‫ﻦ‬  ١  ‫ﻳ‬  ‫ﻨ‬  ‫ﺎ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﺇ‬  ‫ﻟ‬  ‫ﻰ‬  ٣١  ‫ﺩ‬  ‫ﻳ‬  ‫ﺴ‬  ‫ﻤ‬  ‫ﺒ‬  ‫ﺮ‬  ٢٠١٠  ‫ﻡ‬  ٬  ‫ﺑ‬  ‫ﻤ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻯ‬  ‫ﻛ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺗ‬  ‫ﻴ‬  ‫ﻨ‬  ‫ﻴ‬  ‫ﻦ‬  >  ١٬٧  ‫ﻣ‬  ‫ﺠ‬  ‫ﻢ‬  ⁄  ‫ﺩ‬  ‫ﺳ‬  ‫ﻞ‬  ‫ﻓ‬  ‫ﻲ‬  ‫ﻣ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﺸ‬  ‫ﻔ‬  ‫ﻰ‬  ‫ﺭ‬  ‫ﺋ‬  ‫ﻴ‬  ‫ﺲ‬  ‫ﻓ‬  ‫ﻲ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻨ‬  ‫ﻄ‬  ‫ﻘ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺸ‬  ‫ﺮ‬  ‫ﻗ‬  ‫ﻴ‬  ‫ﺔ‬  ،  ‫ﺑ‬  ‫ﺎ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻤ‬  ‫ﻠ‬  ‫ﻜ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻌ‬  ‫ﺮ‬  ‫ﺑ‬  ‫ﻴ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﻌ‬  ‫ﻮ‬  ‫ﺩ‬  ‫ﻳ‬  ‫ﺔ‬  .  ‫ﺗ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﺳ‬  ‫ﺘ‬  ‫ﺨ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﻡ‬  ‫ﻣ‬  ‫ﺮ‬  ‫ﺑ‬  ‫ﻊ‬  ‫ﻛ‬  ‫ﺎ‬  ‫ﻱ‬  ‫ﻭ‬  ‫ﺍ‬  ‫ﺧ‬  ‫ﺘ‬  ‫ﺒ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻻ‬  ‫ﻧ‬  ‫ﺤ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻮ‬  ‫ﺟ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻲ‬  ‫ﻣ‬  ‫ﺘ‬  ‫ﻌ‬  ‫ﺪ‬  ‫ﺩ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺘ‬  ‫ﻐ‬  ‫ﻴ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﻘ‬  ‫ﻴ‬  ‫ﻴ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻌ‬  ‫ﻮ‬  ‫ﺍ‬  ‫ﻣ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺗ‬  ‫ﺒ‬  ‫ﻄ‬  ‫ﺔ‬  ‫ﻻ‬  ‫ﺣ‬  ‫ﺘ‬  ‫ﻤ‬  ‫ﺎ‬  ‫ﻝ‬  ‫ﺯ‬  ‫ﻳ‬  ‫ﺎ‬  ‫ﺩ‬  ‫ﺓ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﻳ‬  ‫ﺘ‬  ‫ﻠ‬  ‫ﻘ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺤ‬  ‫ﻈ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺓ‬  ،  ‫ﻧ‬  ‫ﻈ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﻭ‬  ‫ﺯ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﻃ‬  ‫ﺒ‬  ‫ﺎ‬  ‫ﺀ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﺤ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﺃ‬  ‫ﻧ‬  ‫ﻈ‬  ‫ﻤ‬  ‫ﺔ‬  ‫ﺩ‬  ‫ﻋ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻘ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺤ‬  ‫ﺎ‬  ‫ﺳ‬  ‫ﻮ‬  ‫ﺑ‬  ‫ﻴ‬  ‫ﺔ‬  .   ‫ﺍ‬  ‫ﻟ‬  ‫ﻨ‬  ‫ﺘ‬  ‫ﺎ‬  ‫ﺋ‬  ‫ﺞ‬  :  ‫ﺗ‬  ‫ﻠ‬  ‫ﻘ‬  ‫ﻲ‬  ‫ﻣ‬  ‫ﺎ‬  ‫ﻣ‬  ‫ﺠ‬  ‫ﻤ‬  ‫ﻮ‬  ‫ﻋ‬  ‫ﻪ‬  ٣١٤  ‫ﻣ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﻀ‬  ‫ﺎ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﺍ‬  ‫ﺀ‬  ‫ﻭ‬  ‫ﺍ‬  ‫ﺣ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﻋ‬  ‫ﻠ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﻗ‬  ‫ﻞ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﻲ‬  ‫ﻳ‬  ‫ﺘ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﺨ‬  ‫ﻠ‬  ‫ﺺ‬  ‫ﻣ‬  ‫ﻨ‬  ‫ﻬ‬  ‫ﺎ‬  ‫ﻋ‬  ‫ﻦ‬  ‫ﻃ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﻖ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻴ‬  ‫ﺘ‬  ‫ﻴ‬  ‫ﻦ‬  ‫ﻭ‬  /  ‫ﺃ‬  ‫ﻭ‬  ‫ﻣ‬  ‫ﺤ‬  ‫ﺘ‬  ‫ﻤ‬  ‫ﻠ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻀ‬  ‫ﺮ‬  ‫ﺭ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻜ‬  ‫ﻠ‬  ‫ﻴ‬  ‫ﺘ‬  ‫ﻴ‬  ‫ﻦ‬  .  ‫ﻛ‬  ‫ﺎ‬  ‫ﻥ‬  ١٤  ٪  ‫ﻣ‬  ‫ﻦ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﻩ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﻣ‬  ‫ﺤ‬  ‫ﻈ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻭ‬  ‫ﺃ‬  ‫ﺳ‬  ‫ﻔ‬  ‫ﺮ‬  ‫ﻋ‬  ‫ﻦ‬  ‫ﺗ‬  ‫ﺤ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﻓ‬  ‫ﻲ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻨ‬  ‫ﻈ‬  ‫ﺎ‬  ‫ﻡ‬  ‫ﻭ‬  ‫ﻣ‬  ‫ﻊ‬  ‫ﺫ‬  ‫ﻟ‬  ‫ﻚ‬  ‫ﺃ‬  ‫ﻋ‬  ‫ﻄ‬  ‫ﻴ‬  ‫ﺖ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  .  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺤ‬  ‫ﻈ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺓ‬  ‫ﺣ‬  ‫ﺪ‬  ‫ﺩ‬  ‫ﺕ‬  ‫ﺑ‬  ‫ﺄ‬  ‫ﺭ‬  ‫ﺑ‬  ‫ﻌ‬  ‫ﺔ‬  ‫ﺃ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  :  ‫ﺍ‬  ‫ﻷ‬  ‫ﺳ‬  ‫ﺒ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﻦ‬  ٬  ‫ﻭ‬  ‫ﺟ‬  ‫ﻠ‬  ‫ﻴ‬  ‫ﻜ‬  ‫ﻼ‬  ‫ﺯ‬  ‫ﺍ‬  ‫ﻳ‬  ‫ﺪ‬  ٬  ‫ﻭ‬  ‫ﻧ‬  ‫ﻴ‬  ‫ﺘ‬  ‫ﺮ‬  ‫ﻭ‬  ‫ﻓ‬  ‫ﻴ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻧ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻳ‬  ‫ﻦ‬  ٬  ‫ﻭ‬  ‫ﺳ‬  ‫ﺒ‬  ‫ﻴ‬  ‫ﺮ‬  ‫ﻭ‬  ‫ﻧ‬  ‫ﻮ‬  ‫ﻻ‬  ‫ﻛ‬  ‫ﺘ‬  ‫ﻮ‬  ‫ﻥ‬  ،  ‫ﻭ‬  ‫ﻳ‬  ‫ﻤ‬  ‫ﺜ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺳ‬  ‫ﺒ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﻦ‬  ٦٠  ٪  ‫ﻣ‬  ‫ﻦ‬  ‫ﺟ‬  ‫ﻤ‬  ‫ﻴ‬  ‫ﻊ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﻌ‬  ‫ﻄ‬  ‫ﺎ‬  ‫ﺓ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  .  ‫ﺃ‬  ‫ﻇ‬  ‫ﻬ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﻻ‬  ‫ﻧ‬  ‫ﺤ‬  ‫ﺪ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻠ‬  ‫ﻮ‬  ‫ﺟ‬  ‫ﺴ‬  ‫ﺘ‬  ‫ﻲ‬  ‫ﻣ‬  ‫ﺘ‬  ‫ﻌ‬  ‫ﺪ‬  ‫ﺩ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺘ‬  ‫ﻐ‬  ‫ﻴ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺃ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﺣ‬  ‫ﺘ‬  ‫ﻤ‬  ‫ﺎ‬  ‫ﻻ‬  ‫ﺕ‬  ‫ﺃ‬  ‫ﺧ‬  ‫ﺬ‬  ‫ﻫ‬  ‫ﺬ‬  ‫ﻩ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺩ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﺭ‬  ‫ﺑ‬  ‫ﻌ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺤ‬  ‫ﻈ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﺓ‬  ‫ﺗ‬  ‫ﺰ‬  ‫ﻳ‬  ‫ﺪ‬  ‫ﻟ‬  ‫ﺪ‬  ‫ﻯ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻤ‬  ‫ﺮ‬  ‫ﺿ‬  ‫ﻰ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﻦ‬  ‫ﻳ‬  ‫ﻌ‬  ‫ﺎ‬  ‫ﻧ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﻣ‬  ‫ﻦ‬  ‫ﻗ‬  ‫ﺼ‬  ‫ﻮ‬  ‫ﺭ‬  ‫ﻛ‬  ‫ﻠ‬  ‫ﻮ‬  ‫ﻱ‬  ‫ﺣ‬  ‫ﺎ‬  ‫ﺩ‬  ‫ﺑ‬  ‫ﻌ‬  ‫ﺪ‬  ‫ﺿ‬  ‫ﺒ‬  ‫ﻂ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻌ‬  ‫ﻮ‬  ‫ﺍ‬  ‫ﻣ‬  ‫ﻞ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺨ‬  ‫ﺎ‬  ‫ﺭ‬  ‫ﺟ‬  ‫ﻴ‬  ‫ﺔ‬  .   ‫ﺍ‬  ‫ﻻ‬  ‫ﺳ‬  ‫ﺘ‬  ‫ﻨ‬  ‫ﺘ‬  ‫ﺎ‬  ‫ﺟ‬  ‫ﺎ‬  ‫ﺕ‬  :  ‫ﻻ‬  ‫ﺯ‬  ‫ﺍ‬  ‫ﻝ‬  ‫ﺍ‬  ‫ﻷ‬  ‫ﻃ‬  ‫ﺒ‬  ‫ﺎ‬  ‫ﺀ‬  ‫ﻳ‬  ‫ﺘ‬  ‫ﺠ‬  ‫ﺎ‬  ‫ﻭ‬  ‫ﺯ‬  ‫ﻭ‬  ‫ﻥ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﺤ‬  ‫ﺬ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺘ‬  ‫ﻲ‬  ‫ﺗ‬  ‫ﻘ‬  ‫ﺪ‬  ‫ﻣ‬  ‫ﻬ‬  ‫ﺎ‬  ‫ﺃ‬  ‫ﻧ‬  ‫ﻈ‬  ‫ﻤ‬  ‫ﺔ‬  ‫ﺩ‬  ‫ﻋ‬  ‫ﻢ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﻘ‬  ‫ﺮ‬  ‫ﺍ‬  ‫ﺭ‬  ‫ﺍ‬  ‫ﺕ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺴ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺮ‬  ‫ﻳ‬  ‫ﺔ‬  ‫ﺍ‬  ‫ﻟ‬  ‫ﺤ‬  ‫ﺎ‬  ‫ﺳ‬  ‫ﻮ‬  ‫ﺑ‬  ‫ﻴ‬  ‫ﺔ‬  ‫ﻭ‬  ‫ﻳ‬  ‫ﻘ‬  ‫ﻮ‬  ‫ﻣ‬  ‫ﻮ‬  ‫ﻥ‬  ‫ﺑ‬  ‫ﺈ‬ 
Abstract
Objective: The aim of this study was to determine various types of contraindicated medications that are administered to patients with renal insufficiency by physicians who override alerts provided by the Computerized Decision Support Systems (CDSS).
Methods: This retrospective study incorporated all admitted patients during the period from January 1st through December 31st, 2010, with serum creatinine levels >1.7 mg/dL in a major tertiary hospital in the Eastern Province of the Kingdom of Saudi Arabia (KSA). Chi-square and multivariate logistic regression tests were used to evaluate the factors associated with the increased likelihood of patients receiving contraindicated medication due to physicians overriding the CDSS alert.
Results: A total of 314 patients received at least one medication that was renally cleared and/or potentially nephrotoxic. Fourteen percent of these medications were contraindicated and resulted in a system alert and yet were administered to the patients. The administered contraindicated medications were limited to 4 drugs: aspirin, gliclazide, nitrofurantoin, and spironolactone, with aspirin accounting for approximately 60% of all of the medications received by patients. Multivariate logistic regression showed that the odds of receiving these four contraindicated drugs increased in those with severe renal insufficiency (OR ¼ 23.4, 95% CI 9.9e54.9, p < 0.001) after adjusting for confounding factors.
Conclusion: Physicians override the CDSS alerts and prescribe medications that are contraindicated for patients with renal impairment. These medications are limited in number. This study also emphasizes that the medication database system might need to be updated with input from the physicians using the system.
Introduction
The high prevalence of renal insufficiency in hospital populations and the fact that most drugs and their active metabolites are eliminated through the kidney makes this group of patients highly vulnerable for adverse drug events. 1 Physicians need to consider adjusting the dosage to the level of renal function when prescribing medications to avoid an over dosage, toxicity or further worsening of renal function. With the large number of drugs introduced each year that have varying relationships with the function of the kidney, it is hard for any physician to accurately recall these relations from memory. It is no surprise that several studies have demonstrated high rates of inappropriate dosing for patients with renal insufficiency. 2e4 In a large case-control study, Chertow et al. revealed that the inappropriate prescription of nephrotoxic or renally cleared medications occurred at a rate of 70% in patients hospitalized with renal impairment. 5 In another study, the authors indicated that among 1648 patients, 67% of the drugs prescribed were not adjusted to individual renal function levels. 6 To address this problem, the Institute of Medicine and other influential organizations have endorsed clinical decision support systems (CDSS) as an important strategy for reducing medication errors. 7 In Saudi Arabia, just as in other parts of the world, medication error is a major concern. Khoja et al. found that 18.7% of all of the prescriptions in an inpatient setting are medication errors. 8 In a paediatric setting, Al-Jeraisy et al. found that overall medication errors were present in 56 per 100 medication orders. 9 Even though reducing medication error is important for all of the patients receiving medical care, patients with renal insufficiency are of particular importance. Not only are they at an increased risk of medication errors and adverse drug events but also the prevalence of chronic kidney disease (CKD) in the Kingdom has been increasing at a fast rate over the last three decades as a result of social and demographic changes. 10, 11 With the mandatory introduction of hospital information systems by the Saudi Ministry of Health, integrating CDSS with the Computerized Physician Order Entry (CPOE) can advise physicians on appropriate dosing for patients at varying levels of renal function at the point of care. 12 However, a number of studies have shown that CDSS had limited success in reducing medication errors. 13e15 The most cited explanation was clinician noncompliance with the alert or advice provided by these systems. 16, 17 Frequent clinically unjustified alerts presented to physicians as they enter their drug orders may result in what has been termed "alert fatigue", which may cause physicians to override clinically important alerts or to even totally abandon the decision support system. 18, 19 However, at the same time, medications that result in such alerts are considered by the CDSS knowledge base to be of high risk and are harmful to patients with a compromised kidney reserve. Insight into the medications to which physicians tend to override contraindications may reveal potential problems in the CDSS knowledge database that need to be updated or a lack of knowledge of the medication risks risk by treating physicians that may require more physician training. To better understand these issues, this study aimed to determine the types of contraindicated medications administered to patients with renal insufficiency by physicians who override CDSS alerts in a major Ministry of Health hospital in Saudi Arabia. The study will also examine the factors associated with such overrides.
Materials and Methods

Study setting
This study was conducted in a major Ministry of Health referral hospital providing tertiary care in the Eastern Province, Saudi Arabia. This 600-bed hospital utilizes a commercial electronic medical record (EMR) supported by CDSS that was mandated by the Ministry of Health. This system supports all orders, laboratory results, and patient medication information in the hospital. Computerized order checking for patient-specific parameters with decision support algorithms, including drugedrug interaction, allergies, and drug lab and drug disease interactions, are fully functional. In addition, the system provides advice alerts on drug dosing and avoidance. This study was approved by the Hospital Institutional Review Board.
CDSS and internal logic relevant to renal insufficiency
Each time a newly measured serum creatinine is added by the Lab in the EMR, an estimated creatinine clearance (eCrCl) is calculated according to CockcrofteGault (CG) equation. 20 Utilizing a list of drugs that are either renally cleared and/or are potentially nephrotoxic, the internal logic of the commercial CDSS was designed to trigger an avoid alert if the physician attempts to order one of the contraindicated drugs according to the most recently calculated eCrCl and predetermined safe cut-off point for the drug. The system provides a screen alert message and the established recommendations for completing the order.
Data source
During the one-year period (from January 1st through December 31st, 2009), patients with serum creatinine levels >1.7 mg/dL were candidates to be included in the study. Detailed prescriptions, age, sex, serum creatinine, body weight, and type of treating physician (specialist: yes/no) were abstracted from the electronic medical record. A detailed examination of the data was performed for medications that are renally cleared and/or potentially nephrotoxic. The most recent documented values for weight, serum creatinine and eGFR prior to each prescription of a medication that was renally cleared and/or potentially nephrotoxic were used to estimate kidney function just prior to the prescription of such medication. These medications were then categorized according to the CDSS internal database into two types: 1) contraindicated medications, if the administered medication was considered to be contraindicated given the kidney function just prior to its administration (irrespective to the drug type or group); 2) not a contraindicated medication, if the medication was renally cleared and/or nephrotoxic but not contraindicated given the level of renal function just prior to its administration. Patients <18 years and those who had a renal transplant, were on dialysis, or were diagnosed with acute kidney injury (AKI) were excluded from the study.
Estimation of kidney function
Renal function in adults is usually reported on the basis of eGFR normalized to a body surface area of 1.73 m 2 and derived from the Modification of Diet in Renal Disease (MDRD) formula. However, published information on the effects of renal insufficiency on drug elimination is usually stated in terms of eCrCl as a surrogate for the glomerular filtration rate. For potentially toxic drugs, the eCrCl calculated from the CG formula is used to adjust the dosages. 20 The National Kidney Disease Education Program (NDKEP) in the US recommends that the GFR estimated from the MDRD study or eCrCl estimates from the CG equations for adults can be used for drug dosing. 21 For this study, the two methods used to calculate estimated kidney function were the CockcrofteGault equation 20 and the abbreviated MDRD study equation. 22 Cockcroft À Gault creatinine clearnace ðmL=minÞ 
Statistical analysis
We first described the study population with the means and standard deviations for continuous variables and proportions for categorical variables. Fisher's exact test was used for univariate analysis followed by multivariate logistic regression (enter method) to determine the physician and patient characteristics associated with ordering contraindicated medications. The dependent variable was the admission of a contraindicated medication (yes/no). The independent variables included patient age, sex, severity of renal insufficiency (sever vs. mild/moderate), shift during which the prescription was given (8 ame4 pm/4p me8 am) and day that the prescription was given (weekend/weekday). The physician specialist status (specialist/not specialist) was also included. All analyses were performed using STATA v.11 (Stata Corp, College Station, Texas).
Results
Out of the 314 prescriptions that were renally cleared and/ or potentially nephrotoxic, 44 (14%) were for contraindicated medications. The mean (SD) age of this study group was 54.5 (18.6) years, 55.4% were male, 18.5% had severe renal insufficiency, and approximately 83% of the orders were given by a non-specialist, Table 1 . Table 2 demonstrates that the contraindicated medications ordered were limited to only 4 types, 59.1% (n ¼ 26) were for aspirin, 29.6% (n ¼ 13) were for gliclazide, and 9.1% (n ¼ 4) were for nitrofurantoin; and only one patient received spironolactone. Table 3 presents the patient characteristics according to whether they received one of the four contraindicated medications.
Of the patients who received a contraindicated medication, 56.8% (n ¼ 25) were given to patients aged >65 years compared to 28.2% (n ¼ 76) among patients who did not receive a contraindicated medication, P ¼ 0.001. A high percentage of patients who received contraindicated medications were patients with severe renal insufficiency, 70.5% (n ¼ 31) compared to only 10% (n ¼ 27) among those who were not given a contraindicated medication, P < 0.001. Table 4 presents the results of the multivariate logistic regression confirming that after adjusting for all of the confounding factors, patients with severe renal insufficiency were more likely to receive one of the four contraindicated medications despite the alert compared to patients with a milder renal insufficiency (OR 23.4, 95% CI 9.9e54.9; P < 0.001).
Discussion
In this study, 314 patients with serum creatinine >1.7 mg/ dL received at least one medication that was renally cleared and/or potentially nephrotoxic. Fourteen percent of those were for contraindicated medications that resulted in a system alert and were still administered to the patients by the ordering physician despite the alert. Administered contraindicated medications included 4 drugs: aspirin, gliclazide, nitrofurantoin, and spironolactone with aspirin, which accounted for approximately 60% of these medications.
Several studies on the effectiveness of CDSS alerts to reduce the prescription of the contraindicated medications to patients with a renal insufficiency found a wide range of effectiveness of alerts by these systems, with most of these studies finding reduced levels of effectiveness, mostly due to noncompliance by physicians. 5,23e25 In our study, and similar to other studies, the administration of contraindicated medications to patients with renal insufficiency is still high in hospitals that implemented CDSS, although it is lower compared to previous studies: 14% in our study vs. a range of 19.9%e47% among other studies. 17, 26, 27 There are three main explanations for the discrepancy between our study and the previous studies. First, a variation in the definition of error could explain this difference. In our study, error was defined as administering drugs that are contraindicated given the level of renal impairment, while other studies defined error as a combination of the administration of contraindicated drugs and/or the administration of an inappropriate dose. Second, there are major variations in the drug information sources used by the systems in these different studies. 28 Some drugs that are marked as contraindicated in one source are not considered to be such in another source. Third, there are variations in the definition and classification of renal impairment among these sources; some sources categorized renal function into five different stages, 29 while others divided renal function into three categories, which leads to some drugs being considered to be contraindicated in some studies but not in others. 30 In a study by Salomon et al., 31 in a setting with no CDSS system, the authors found that among 886 prescriptions that were four drugs that were either renally cleared and/or potentially nephrotoxic, 14% received contraindicated medications, which is similar to the percentage in our study hospital with a fully functioning CDSS system. This might indicate that physicians in our study hospital were noncompliant to the system alerts. Our study did not interview physicians to determine their reasons for noncompliance with the decision support recommendations. However, some of the causes for noncompliance have been examined in previous studies. 32e34 One proposed cause is that CDSS systems provide alerts for reordering or renewing medication orders that were previously tolerated by the patient. 33 Noncompliance can also result when the physician feels that he/she knows more about the specific clinical condition of the patient than the CDSS. Physicians often see their patients on a daily basis and are likely to be familiar with changes in their medical condition. This level of information may not be available to the CDSS or may be in a format that cannot be utilized by the logic of the system. 34 Another factor that was suggested is the clinical usefulness of the alert itself. Spina et al. 32 found that 86% of the alerts were actually not useful. On the other hand, it is also possible that noncompliance could be caused by a lack of knowledge among physicians about the necessity of withholding such medications in patients with a renal insufficiency. 23 In our study, most of the overridden orders were for aspirin. Other overridden orders were for nitrofurantoin, gliclazide, and spironolactone. Interestingly, the chronic effects of these medications on the progression of renal insufficiency, as presented in the literature, are contradicting and inconclusive at best. For example, the BNF indicates that aspirin should be used with caution and should to be avoided in cases of severe renal impairment. 35 Others have also indicated that aspirin has exacerbating effects in patients with CKD in a dose-dependent manner. 36 That is in contrast to other studies that indicated that aspirin might be safe for use in patients with diagnosed advanced renal insufficiency stages 4e5 without an adverse effect on the progression of the disease. 37 BNF indicated that nitrofurantoin should be avoided altogether if the eGFR is less than 60 mL/min. 35 Furthermore, nitrofurantion product information also indicated that it is contraindicated in patients with eCrCl values below 60 ml/min. 38 In contrast, the literature review by Oplinger et al. indicated that the data supporting the contraindication of nitrofurantoin for patients with eCrCl values less than 60 mL/min are nonexistent. 39 Gliclazide, like other sulfonylureas, has increased potency as the renal function decreases and is considered in some literature to be contraindicated in severe renal failure. 40 Other recent studies, however, indicated that it is a preferred sulfonylurea with no need for dose adjustment. 41 Finally, spironolactone is considered by some published studies to be well tolerated in select patients with early stage renal insufficiency, although strict monitoring over the first few months is suggested. 42 Given this inconsistency, it is possible that the physicians in this study hospital are not only accustomed to and frequently use these medications in everyday practice but are also familiar with the indecisiveness about the effect of these medications in the medical community. It is no surprise that many physician override the avoid alert when they try to administer these drugs to their patients.
Our study investigated the factors that are associated with noncompliance and the eventual receipt of one of these four contraindicated medications. Older people were at a higher risk for receiving these contraindicated medications. We also found a surprising negative association between noncompliance with these medications and the level of renal dysfunction. Salomon et al. 31 suggested that this unexpected pattern does not reflect the quality of the physician order but the fact that the same medication order that is considered to be contraindicated in patients with severe renal insufficiency is considered to be appropriate in patients with mild/ moderate renal insufficiency. We believe that more studies are needed to verify Salomon's argument.
There are several limitations of the current study. First, the study was conducted in only one Ministry of Health affiliated hospital using a commercial CDSS system. Accordingly, the results may not be generalizable to other hospitals or other systems. Second, this study did not examine the adverse effects on the involved patients; therefore, we do not know what harmful effect, if any, the overridden alerts had on these patients. Third, the unavailability of the data on the demographic characteristics of both the patients and treating physicians, other comorbidities, and main underlining disease of the patient is another limitation of the study. Including these factors in our analysis would have better explained the different reasons that physicians override alerts.
Conclusion
Our study has two main conclusions. First, physicians override the CDSS alerts and prescribe medications that are considered to be contraindicated by the CDSS knowledge database for patients with reduced renal function. Second, these medications are limited in number, and thus, physicians could be encouraged to replace these medications with other safer medications or at least be educated about the contraindications. More studies are needed to determine physicians' perceptions about the system and the factors related to their noncompliance to its alerts. More studies are also needed to evaluate the system information, system integration, and its alliance with the organizational and clinical workflow.
The paucity of these types of studies in Saudi Arabia makes this study of great importance and an incentive for future studies, particularly as the Saudi government is moving forward with implementing these systems in hospitals nationwide. Decision makers need to realize that such research must guide the development of new hospital information technology, particularly in relation to the selection of future systems and their flexibility to be adjusted to accommodate physicians' experience and evidence based medicine.
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